GLP1R and medullary thyroid gland carcinoma: There were concerns about a possible increased risk of developing medullary thyroid carcinoma (MTC) after an association was noted in rodent studies between long-acting GLP-1 RA (such as liraglutide) and thyroid parafollicular C-cell hyperplasia.